Chronic Kidney Disease, Stage 5 clinical trials
54 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment
- A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
- Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
- Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
- Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- Comparing Surgical and Endovascular Arteriovenous Fistula Creation
- Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
- AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
- Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
- Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Virtual Reality in End Stage Kidney Disease
- Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial
- Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
- Solv Multi-Pass Hemodialysis System In-Center Clinical Study
- A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Pivotal Study of the Velocity™ pAVF System
- A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Combination of Novel Therapies for CKD Comorbid Depression
- REgulatory T Cell Therapy to Achieve Immunosuppression REduction
- Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
- Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
- CAPABLE Transplant
- Safety and Efficacy of Empagliflozin in Hemodialysis
- CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
- A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
- Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
- EndoForce Post Approval Study
- PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
- Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
- Duke APOL1 Research Biorepository
- Drug Interaction Potential of Pro-Inflammatory Conditions
- Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
- Disparities Among Liver Transplant Patients
- Partners Calciphylaxis Biobank
- RaDIANT Health Systems Intervention
- Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
- Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD
- ACP Video Intervention for Patients With Life-Limiting Illness
- Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
- Symptom Monitoring in Hemodialysis
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
- Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
- Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease
- Dry Weight Reduction Intervention Via Extra Ultrafiltration
- Prospective Analysis of Arteriovenous Access (AVA) Use in Continuous Renal Replacement Therapy: A Feasibility Project
- Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3
- Xeltis Hemodialysis Access Graft (aXess) US Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Chronic Kidney Disease, Stage 5” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.